Go Back
Sage Therapeutics, Inc. reports $146.8 million Q1 loss
By USInMinutes - May 02, 2023, 09:24 AM ET
Last Updated - Jul 18, 2023, 03:45 PM EDT
The company generated $3.30 million in quarterly revenue
Sage Therapeutics, Inc. [SAGE] has reported fiscal Q1 loss of $146.80 million.
On a per-share basis, the DE based company said its diluted earnings are $2.46.
The Pharmaceutical Preparations firm posted revenue of $3.30 million in this period.
Also Read:
- Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
- Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023
- Sage Therapeutics to Present at the Stifel 2023 CNS Days
- Sage Therapeutics to Provide Update on 2023 Key Initiatives at 41st Annual J.P. Morgan Healthcare Conference
- Sage Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News
